• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳房间化脓性汗腺炎:关于一种独特表现的思考

Intermammary Hidradenitis Suppurativa: Considerations on a Unique Presentation.

作者信息

João Ana Luísa, Cunha Nélia, Cabete Joana

机构信息

Dermatology Department, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.

出版信息

Skin Appendage Disord. 2021 Jun;7(4):318-321. doi: 10.1159/000514363. Epub 2021 Mar 22.

DOI:10.1159/000514363
PMID:34307482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8280451/
Abstract

INTRODUCTION

Hidradenitis suppurativa (HS) is a potentially disabling chronic inflammatory disease. The intermammary location, not clearly specified in the usual phenotypic classifications, entails significant functional and cosmetic compromise.

CASE PRESENTATION

Eleven cases of predominantly intermammary disease with multiple fistulization and disfiguring scarring were observed at our Department between January 2016 and March 2020. They were young (mean age = 22 years) obese or overweight women, in which the medical-surgical approach has led to variable results.

DISCUSSION/CONCLUSION: Intermammary HS possibly represents a unique phenotypic presentation, likely to be fistulizing and severe. We believe that anatomo-functional considerations, which can be paralleled to pilonidal sinus disease, contribute to its pathophysiology and striking appearance, and further emphasize the importance of multidisciplinary endeavor to reduce the morbidity associated with this seemingly overlooked location.

摘要

引言

化脓性汗腺炎(HS)是一种可能导致功能障碍的慢性炎症性疾病。乳房间部位在通常的表型分类中未明确界定,会导致严重的功能和外观损害。

病例报告

2016年1月至2020年3月期间,我们科室观察到11例以乳房间疾病为主、伴有多处瘘管形成和毁容性瘢痕的病例。患者均为年轻(平均年龄22岁)的肥胖或超重女性,内科-外科联合治疗取得了不同的效果。

讨论/结论:乳房间HS可能代表一种独特的表型表现,可能会形成瘘管且病情严重。我们认为,与藏毛窦疾病类似的解剖学-功能学因素有助于其病理生理过程和显著外观的形成,并进一步强调了多学科协作对于降低与这一似乎被忽视部位相关发病率的重要性。

相似文献

1
Intermammary Hidradenitis Suppurativa: Considerations on a Unique Presentation.乳房间化脓性汗腺炎:关于一种独特表现的思考
Skin Appendage Disord. 2021 Jun;7(4):318-321. doi: 10.1159/000514363. Epub 2021 Mar 22.
2
Intermammary Hidradenitis Suppurativa: A Case Report.乳房间化脓性汗腺炎:一例报告
Int Med Case Rep J. 2022 Apr 11;15:163-167. doi: 10.2147/IMCRJ.S358514. eCollection 2022.
3
Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.皮肤科和性病科在莫斯塔尔临床医院用阿达木单抗治疗两例化脓性汗腺炎。
Acta Dermatovenerol Croat. 2021 Jul;29(2):108-110.
4
Intermammary pilonidal sinus: The first case series.乳房间藏毛窦:首例病例系列报道
Int J Surg Case Rep. 2017;41:265-268. doi: 10.1016/j.ijscr.2017.10.021. Epub 2017 Oct 20.
5
Hidradenitis Suppurativa at an Uncommon Site: A Review of Its Clinical Features, Diagnostic Difficulties, and Management.罕见部位的化脓性汗腺炎:临床特征、诊断难点及治疗综述
Cureus. 2021 Oct 12;13(10):e18704. doi: 10.7759/cureus.18704. eCollection 2021 Oct.
6
Boils at Frictional Locations in a Patient with Hidradenitis Suppurativa.化脓性汗腺炎患者摩擦部位的疖肿
Acta Dermatovenerol Croat. 2016 Dec;24(4):303-304.
7
Disfiguring Hidradenitis Suppurativa of the Face.面部毁容性化脓性汗腺炎
Skin Appendage Disord. 2022 Jan;8(1):70-72. doi: 10.1159/000518433. Epub 2021 Aug 26.
8
Disseminate recurrent folliculitis as the presenting picture of hidradenitis suppurativa.播散性复发性毛囊炎作为化脓性汗腺炎的表现形式。
Ann Dermatol Venereol. 2017 Nov;144(11):715-718. doi: 10.1016/j.annder.2017.03.026. Epub 2017 Aug 31.
9
Sonographic Comparison of Morphologic Characteristics Between Pilonidal Cysts and Hidradenitis Suppurativa.藏毛窦与化脓性汗腺炎形态学特征的超声比较
J Ultrasound Med. 2017 Dec;36(12):2403-2418. doi: 10.1002/jum.14282. Epub 2017 Jun 26.
10
Pilonidal sinus disease: an intergluteal localization of hidradenitis suppurativa/acne inversa: a cross-sectional study among 2465 patients.藏毛窦疾病:化脓性汗腺炎/反向痤疮的臀间定位:2465 例患者的横断面研究。
Br J Dermatol. 2019 Dec;181(6):1198-1206. doi: 10.1111/bjd.17927. Epub 2019 May 6.

引用本文的文献

1
Intermammary Hidradenitis Suppurativa.乳房间化脓性汗腺炎
Skin Appendage Disord. 2022 Jul;8(4):312-313. doi: 10.1159/000521740. Epub 2022 Jan 26.
2
Intermammary Hidradenitis Suppurativa: A Case Report.乳房间化脓性汗腺炎:一例报告
Int Med Case Rep J. 2022 Apr 11;15:163-167. doi: 10.2147/IMCRJ.S358514. eCollection 2022.

本文引用的文献

1
Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis.化脓性汗腺炎:流行病学、临床表现和发病机制。
J Am Acad Dermatol. 2020 May;82(5):1045-1058. doi: 10.1016/j.jaad.2019.08.090. Epub 2019 Oct 9.
2
Hidradenitis suppurativa: Current and emerging treatments.化脓性汗腺炎:现有及新兴疗法。
J Am Acad Dermatol. 2020 May;82(5):1061-1082. doi: 10.1016/j.jaad.2019.08.089. Epub 2019 Oct 9.
3
Surgical Treatment of Intermammary Hidradenitis Suppurativa With a 3-Point Advancement Flap (Mercedes Closure).采用三点推进皮瓣(梅赛德斯闭合术)治疗乳房间化脓性汗腺炎
Dermatol Surg. 2020 Nov;46(11):1457-1460. doi: 10.1097/DSS.0000000000002102.
4
Pilonidal sinus disease: an intergluteal localization of hidradenitis suppurativa/acne inversa: a cross-sectional study among 2465 patients.藏毛窦疾病:化脓性汗腺炎/反向痤疮的臀间定位:2465 例患者的横断面研究。
Br J Dermatol. 2019 Dec;181(6):1198-1206. doi: 10.1111/bjd.17927. Epub 2019 May 6.
5
New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes.深入了解化脓性汗腺炎的诊断:临床表现和表型。
J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S23-6. doi: 10.1016/j.jaad.2015.07.047.
6
Anatomical Network Comparison of Human Upper and Lower, Newborn and Adult, and Normal and Abnormal Limbs, with Notes on Development, Pathology and Limb Serial Homology vs. Homoplasy.人类上下肢、新生儿与成人以及正常与异常肢体的解剖网络比较,并附发育、病理学以及肢体系列同源性与同功性的注释
PLoS One. 2015 Oct 9;10(10):e0140030. doi: 10.1371/journal.pone.0140030. eCollection 2015.
7
Follicular occlusion tetrad.毛囊闭锁四联症
Indian Dermatol Online J. 2014 Oct;5(4):491-3. doi: 10.4103/2229-5178.142517.
8
The behaviour of presternal scars in a fair-skinned population.白皙皮肤人群胸前瘢痕的表现。
Ann R Coll Surg Engl. 1985 Jul;67(4):238-40.